Add Yahoo as a preferred source to see more of our stories on Google. Addyi is the brand name for a prescription drug that treats hypoactive sexual desire disorder (HSDD), the medical term for low sex ...

When it comes to sec, while the act might be loud, the talk around has been in a hush-hush zone for years. Especially when it comes to women. While you might find podcasts and influencers discussing ...

Addyi and Vyleesi are medications for boosting sexual desire in women. Addyi is taken daily at bedtime, while Vyleesi is ...

When it comes to a woman's health, Addyi is a vital medication. It can provide relief from the symptoms of female sexual dysfunction and help women to enjoy sex again. With the right insurance ...

Digital Journal reported on August 18, 2015, that Addyi, a drug that works on the brain to boost younger women’s libido if they have lost interest in sex, was given approval by the Food and Drug ...

Sprout joins the ranks of biotech's biggest names following record-setting growth, expanding prescriber adoption, and increasing payer coverage RALEIGH, N.C., April 29, 2026 /PRNewswire/ -- TIME has ...

The MarketWatch News Department was not involved in the creation of this content. Recognition follows Addyi's newly expanded FDA approval to treat both premenopausal and postmenopausal women under age ...

Addyi, sometimes referred to as "female Viagra," is now approved for use to treat low sex drive in postmenopausal women. MoMo Productions/Getty Images The Food and Drug Administration (FDA) expanded ...

WASHINGTON -- The Food and Drug Administration on Tuesday approved the first prescription drug designed to boost sexual desire in women, a milestone long sought by a pharmaceutical industry eager to ...

In the often unspoken world of female sexual health, a revolution has started, and it began with the introduction of a unique medication called Addyi. Traditionally, when we think of sexual ...

The FDA expanded its approval of Addyi, a pill to treat low libido in women, to include postmenopausal women up to age 65. The approval will open up new treatment options for older women, but experts ...